How do you calculate the alveolar-arterial (A-a) oxygen gradient in an adult patient with a potential hemoglobinopathy or condition affecting oxygen binding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 30, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the alveolar gas equation, its clinical applications, and the significance of the alveolar-arterial (A-a) oxygen gradient in respiratory physiology and disease management?

What is the significance of the alveolar-arterial (A-a) gradient in respiratory physiology?

What is the formula to calculate the desired fraction of inspired oxygen (FiO₂) to achieve a target arterial oxygen tension (PaO₂) given the patient's current PaCO₂?

What is a normal alveolar-arterial (A-a) gradient?

What is the significance of the Alveolar-arterial (A-a) gradient in respiratory physiology?

What is the best initial diagnostic test to rule out a mass in the left leg groin area?

What is the best course of action for a patient with diarrhea, heartburn, and dizziness?

What are the management and treatment options for an adult with no significant past medical history (PMH) who has been exposed to mouse droppings and is at risk for hantavirus infection, particularly hantavirus pulmonary syndrome (HPS)?

What is the best approach for treating a patient with acute magnesium deficiency?

What is the difference between palliative and adjuvant (additional) treatments for a patient with a serious illness, such as cancer, and how are they determined based on the patient's condition, medical history, and current health status?

What is the best medication to add to the treatment regimen of a patient with heart failure with reduced ejection fraction (HFrEF) and dilated cardiomyopathy who is already on Valsartan (Angiotensin II receptor antagonist), a statin (HMG-CoA reductase inhibitor), Metoprolol (beta-blocker), Spironolactone (aldosterone antagonist), and Furosemide (loop diuretic)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.